Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
Summary
Cellular senescence is a conserved stress-responsive program defined by durable proliferative arrest and extensive remodeling of chromatin, metabolism, intercellular signaling, and immune interactions. Initially described as a barrier to unlimited cell division, senescence is now recognized as a pleiotropic and heterogeneous biological process with roles in development, tissue repair, immune surveillance, tumor suppression, aging, fibrosis, and cancer progression. Despite its broad relevan
Content
# Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
*Published: 2026 Apr 16*
Cellular senescence is a conserved stress-responsive program defined by durable
proliferative arrest and extensive remodeling of chromatin, metabolism,
intercellular signaling, and immune interactions. Initially described as a
barrier to unlimited cell division, senescence is now recognized as a
pleiotropic and heterogeneous biological process with roles in development,
tissue repair, immune surveillance, tumor suppression, aging, fibrosis, and
cancer progression. Despite its broad relevance, senescence remains challenging
to define operationally, as its molecular features, functional outputs, and
physiological consequences vary across cell types, tissues, and stimuli. This
review summarizes core hallmarks of senescence while synthesizing how these
features are differentially engaged, diversified, and repurposed across
biological contexts. Focusing on cancer, we discuss how senescence influences
tumor initiation, evolution, and therapeutic response through both
cell-intrinsic and microenvironmental mechanisms. We further evaluate emerging
strategies to therapeutically modulate senescence, highlighting both
opportunities and unresolved challenges for precision intervention.
DOI: 10.1016/j.cell.2026.03.005